Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in arrhythmia therapy.

J Rodman, D Benditt

    Clinical Pharmacy
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Recent advancements in cardiac arrhythmia classification and treatment are reviewed. New monitoring and testing methods improve understanding and management of potentially life-threatening arrhythmias, especially in heart attack survivors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
    Same author

    Parallel evolution of glucosinolate biosynthesis inferred from congruent nuclear and plastid gene phylogenies.

    American journal of botany·2011
    Same author

    Responses to weight loss treatment among obese individuals with and without BED: a matched-study meta-analysis.

    Eating and weight disorders : EWD·2007
    Same author

    [The adenosine-5'-triphosphate (ATP) test: a diagnostic tool in the management of syncope of unknown origin. Basic and clinical aspects].

    Annales de cardiologie et d'angeiologie·2005
    Same author

    Task force on syncope, European Society of Cardiology. Part 1. The initial evaluation of patients with syncope.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2001
    Same author

    Task force on syncope, European Society of Cardiology. Part 2. Diagnostic tests and treatment: summary of recommendations.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2001
    Same journal

    Criteria for use of epoetin alfa in adult cancer and orthopedic-surgery patients.

    Clinical pharmacy·1993
    Same journal

    Accuracy of unbound-quinidine concentration determination after ultrafiltration.

    Clinical pharmacy·1993
    Same journal

    Modified Michaelis-Menten equation for estimating unbound-phenytoin concentrations.

    Clinical pharmacy·1993
    Same journal

    Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.

    Clinical pharmacy·1993
    Same journal

    Efficacy of nutritional supplements used by athletes.

    Clinical pharmacy·1993
    Same journal

    Low-molecular-weight heparins for the treatment of deep-vein thrombosis.

    Clinical pharmacy·1993
    See all related articles

    Area of Science:

    • Cardiology
    • Electrophysiology

    Background:

    • Cardiac arrhythmias require updated classification and treatment strategies.
    • Advancements in monitoring and invasive testing have improved the study of arrhythmia mechanisms.

    Purpose of the Study:

    • To review recent developments in the classification and treatment of cardiac arrhythmias.
    • To discuss the impact of new technologies and drugs on arrhythmia management.

    Main Methods:

    • Review of recent studies and clinical trials.
    • Analysis of new diagnostic techniques, including ambulatory electrocardiogram monitoring and invasive electrophysiological testing.
    • Evaluation of novel antiarrhythmic drugs in clinical testing.

    Main Results:

    Related Experiment Videos

  • Reassessment of arrhythmia and antiarrhythmic drug classification schemes.
  • Improved understanding of the clinical significance of different arrhythmias.
  • Identification of life-threatening sustained ventricular tachyarrhythmias requiring aggressive treatment.
  • Demonstrated efficacy of beta-adrenergic antagonists in preventing sudden death post-myocardial infarction.

    • Conclusions:

    • Occasional supraventricular tachycardias generally do not increase mortality.
    • Sustained ventricular tachyarrhythmias are a significant risk, particularly in coronary artery disease patients.
    • Beta-blockers are crucial for post-myocardial infarction mortality reduction.
    • Further research is needed for broader patient populations beyond recent myocardial infarction.